Increasing and planned dose intensity of doxorubicin, cyclophosphamide and etoposide (ACE) by adding recombinant human methionyl granulocyte colony-stimulating factor (G-CSF; filgrastim) in the treatment of small cell lung cancer (SCLC)
- 31 December 1995
- journal article
- clinical trial
- Published by Elsevier in Clinical Oncology
- Vol. 7 (5) , 293-299
- https://doi.org/10.1016/s0936-6555(05)80536-9
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: